Tectonic Therapeutic (TECX) Equity Ratio (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Equity Ratio data on file, last reported at 0.93 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.93, down 2.27% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.93 (down 2.27% YoY), and the FY2025 annual result was 0.96, up 4.58% from the prior year.
• Equity Ratio retreated to 0.93 in Q1 2026 per TECX's latest filing, from 0.96 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.97 in Q3 2025 and troughed at 2.15 in Q4 2023.
• A 5-year average of 0.25 and a median of 0.82 in 2022 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2023 and 2024: Equity Ratio slumped 389.12% in 2023, then surged 264.03% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.44 in 2022, then tumbled by 389.12% to 2.15 in 2023, then soared by 142.86% to 0.92 in 2024, then gained by 4.58% to 0.96 in 2025, then decreased by 2.94% to 0.93 in 2026.
• Business Quant data shows TECX's Equity Ratio at 0.93 in Q1 2026, 0.96 in Q4 2025, and 0.97 in Q3 2025.